| scholarly article | Q13442814 |
| P2093 | author name string | Oaks EV | |
| Eckels KH | |||
| Schultz CL | |||
| Hartman AB | |||
| Powell CJ | |||
| P2860 | cites work | Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. | Q54712481 |
| Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population | Q68134308 | ||
| Local and systemic antibody responses to Shigella infection in rhesus monkeys | Q68944588 | ||
| Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 | ||
| Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin | Q69362834 | ||
| Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati) | Q70422370 | ||
| Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment | Q78615786 | ||
| Acquired natural immunity following recovery from keratoconjunctivitis shigellosa | Q78914365 | ||
| The use of the guinea-pig conjunctivae as an experimental model for the study of virulence of Shigella organisms | Q79064584 | ||
| A new method for the measurement of protective potency of dysentery vaccines | Q79415761 | ||
| ??? | Q94264873 | ||
| Sequence and molecular characterization of a multicopy invasion plasmid antigen gene, ipaH, of Shigella flexneri | Q33253819 | ||
| New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development | Q33628356 | ||
| Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneri | Q33682684 | ||
| Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains | Q36720620 | ||
| Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei | Q36985066 | ||
| Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp | Q37010733 | ||
| Development of an auxotrophic oral live Shigella flexneri vaccine | Q39227963 | ||
| Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen | Q40168452 | ||
| Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 | ||
| Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp. | Q41186719 | ||
| Hybrid vaccines using Escherichia coli as an antigen carrier | Q41511130 | ||
| Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials | Q42175413 | ||
| Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines | Q42966608 | ||
| Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis | Q44965347 | ||
| Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes | Q46853037 | ||
| Failure of parenteral vaccines to protect monkeys against experimental shigellosis | Q47710064 | ||
| Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine | Q50201269 | ||
| Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 | ||
| Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication. | Q54331405 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4075-4083 | |
| P577 | publication date | 1991-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains | |
| P478 | volume | 59 |
| Q40126474 | An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype. |
| Q46174437 | An environmental Escherichia albertii strain, DM104, induces protective immunity to Shigella dysenteriae in guinea pig eye model |
| Q34941041 | Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants |
| Q35411990 | Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q91801457 | Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies |
| Q35548702 | Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1. |
| Q39573053 | Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model |
| Q39655324 | Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine |
| Q46938617 | Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine |
| Q37643320 | Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. |
| Q37713347 | Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies |
| Q42262595 | Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model |
| Q42701095 | Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella |
| Q40460000 | Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain. |
| Q40123700 | Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. |
| Q40267400 | Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. |
| Q50176712 | Improving chances for successful clinical outcomes with better preclinical models |
| Q39569905 | Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. |
| Q33454924 | Involvement of RNA-binding protein Hfq in the osmotic-response regulation of invE gene expression in Shigella sonnei |
| Q39517102 | Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine |
| Q35772614 | Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. |
| Q34006071 | Parameters underlying successful protection with live attenuated mutants in experimental shigellosis |
| Q38294092 | Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta) |
| Q84592118 | Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine |
| Q36945836 | Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. |
| Q39516481 | Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages |
| Q35227831 | Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a |
| Q34518265 | Status of vaccine research and development for Shigella |
| Q34000330 | Strategy for cross-protection among Shigella flexneri serotypes |
| Q39836106 | Temperature-regulated expression of outer membrane proteins in Shigella flexneri |
| Q40300987 | The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence. |
| Q33876803 | Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602 |
| Q33557800 | Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants |
Search more.